Loefflers syndrome differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3 | ||
|- | |- | ||
| rowspan="5" |Helminthic and fungal infection-related eosinophilic lung diseases | | rowspan="5" |Helminthic | ||
and | |||
fungal | |||
infection- | |||
related eosinophilic lung | |||
diseases | |||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary passage of larvae (Loffler's syndrome) | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary passage of larvae (Loffler's syndrome) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 171: | Line 180: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" |Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) | | colspan="2" |Eosinophilic | ||
granulomatosis | |||
with | |||
polyangiitis | |||
(Churg-Strauss) | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 188: | Line 204: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| colspan="2" |Drug | | colspan="2" |Drug | ||
and | |||
toxin- | |||
induced | |||
eosinophilic | |||
lung | |||
diseases | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 23:12, 14 May 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Loeffler syndrome must be differentiated from other diseases that cause pulmonary eosinophilia, such as Churg-Strauss, drug and toxin-induced eosinophilic lung diseases, other helminthic and fungal infection related eosinophilic lung diseases, and nonhelminthic infections such as Coccidioidomycosis, and Mycobacterium tuberculosis, .
Differentiating Loeffler syndrome from other pulmonary eosinophilia syndromes on the basis of etiology.
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | Imaging | Histopathology | ||||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Increased Eosinophil count
(High) |
Increased Eosinophil count
(Mild to moderate) |
Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | |||||
Helminthic
and fungal infection- related eosinophilic lung diseases |
Transpulmonary passage of larvae (Loffler's syndrome) |
| ||||||||||||||
Tropical pulmonary eosinophilia | 40 to 70 percent |
| ||||||||||||||
Allergic bronchopulmonary aspergillosis | * | |||||||||||||||
Heavy hematogenous seeding with helminths |
| |||||||||||||||
Pulmonary parenchymal invasion |
| |||||||||||||||
Nonhelminthic infections | Coccidioidomycosis | |||||||||||||||
Mycobacterium tuberculosis | ||||||||||||||||
Eosinophilic
granulomatosis with polyangiitis (Churg-Strauss) |
* | |||||||||||||||
Drug
and toxin- induced eosinophilic lung diseases |
* |
| ||||||||||||||
Acute eosinophilic pneumonia | ||||||||||||||||
Chronic eosinophilic pneumonia | ≥40 percent | |||||||||||||||
Idiopathic acute eosinophilic pneumonia | ≥25 percent | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Increased Eosinophil count
(High) |
Increased Eosinophil count
(Mild to moderate) |
Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings | |
Sarcoidosis | * | |||||||||||||||
Pulmonary Langerhans cell histiocytosis (Histiocytosis X) | * | |||||||||||||||
Idiopathic pulmonary fibrosis | <10 percent | |||||||||||||||
Differential Diagnosis 7 |